Industry leaves poverty-related research:
This article was originally published in Clinica
Executive Summary
Industry has been discouraged from investing in research to tackle poverty-related diseases, such as malaria, tuberculosis and AIDS, because of the lack of returns. It is now up to the European Community to fill this gap by giving its financial support, EU Research Commissioner Philippe Busquin has said. Speaking at the launch of the European Commission's programme of clinical trials for poverty-related diseases he said that the programme will improve the impact of public investment by allowing a more coherent and targeted approach. He added that the clinical trials programme will help create a critical mass of research competence and establish a more structured partnership. The European Community is allocating E200 million ($182 million) to the programme over five years under the Sixth Framework Programme for research.